Literature DB >> 22388295

Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.

Rochelle R Arvizo1, Sanjib Bhattacharyya, Rachel A Kudgus, Karuna Giri, Resham Bhattacharya, Priyabrata Mukherjee.   

Abstract

Biomedical nanotechnology is an evolving field having enormous potential to positively impact the health care system. Important biomedical applications of nanotechnology that may have potential clinical applications include targeted drug delivery, detection/diagnosis and imaging. Basic understanding of how nanomaterials, the building blocks of nanotechnology, interact with the cells and their biological consequences are beginning to evolve. Noble metal nanoparticles such as gold, silver and platinum are particularly interesting due to their size and shape dependent unique optoelectronic properties. These noble metal nanoparticles, particularly of gold, have elicited a lot of interest for important biomedical applications because of their ease of synthesis, characterization and surface functionalization. Furthermore, recent investigations are demonstrating another promising application of these nanomaterials as self-therapeutics. To realize the potential promise of these unique inorganic nanomaterials for future clinical translation, it is of utmost importance to understand a few critical parameters; (i) how these nanomaterials interact with the cells at the molecular level; (ii) how their biodistribution and pharmacokinetics influenced by their surface and routes of administration; (iii) mechanism of their detoxification and clearance and (iv) their therapeutic efficacy in appropriate disease model. Thus in this critical review, we will discuss the various clinical applications of gold, silver and platinum nanoparticles with relevance to above parameters. We will also mention various routes of synthesis of these noble metal nanoparticles. However, before we discuss present research, we will also look into the past. We need to understand the discoveries made before us in order to further our knowledge and technological development (318 references).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22388295      PMCID: PMC3346960          DOI: 10.1039/c2cs15355f

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  235 in total

Review 1.  Synthesis and optical properties of silver nanoparticles and arrays.

Authors:  David D Evanoff; George Chumanov
Journal:  Chemphyschem       Date:  2005-07-11       Impact factor: 3.102

Review 2.  Pushing nanocrystal synthesis toward nanomanufacturing.

Authors:  Sara E Skrabalak; Younan Xia
Journal:  ACS Nano       Date:  2009-01-27       Impact factor: 15.881

3.  Synthesis and catalytic properties of soluble platinum nanoparticles protected by a thiol monolayer.

Authors:  Sven E Eklund; David E Cliffel
Journal:  Langmuir       Date:  2004-07-06       Impact factor: 3.882

4.  Nitrate reductase-mediated synthesis of silver nanoparticles from AgNO3.

Authors:  S Anil Kumar; Majid Kazemian Abyaneh; S W Gosavi; Sulabha K Kulkarni; Renu Pasricha; Absar Ahmad; M I Khan
Journal:  Biotechnol Lett       Date:  2007-01-20       Impact factor: 2.461

5.  Size-dependent cytotoxicity of gold nanoparticles.

Authors:  Yu Pan; Sabine Neuss; Annika Leifert; Monika Fischler; Fei Wen; Ulrich Simon; Günter Schmid; Wolfgang Brandau; Willi Jahnen-Dechent
Journal:  Small       Date:  2007-11       Impact factor: 13.281

6.  Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells.

Authors:  Chae Kyu Kim; Partha Ghosh; Chiara Pagliuca; Zheng-Jiang Zhu; Stefano Menichetti; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2009-02-04       Impact factor: 15.419

7.  Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings.

Authors:  Héctor Rosas-Hernández; Salma Jiménez-Badillo; Pedro P Martínez-Cuevas; Eduardo Gracia-Espino; Humberto Terrones; Mauricio Terrones; Saber M Hussain; Syed F Ali; Carmen González
Journal:  Toxicol Lett       Date:  2009-10-02       Impact factor: 4.372

8.  Effects of silver nanoparticles on the development and histopathology biomarkers of Japanese medaka (Oryzias latipes) using the partial-life test.

Authors:  Yuan Wu; Qunfang Zhou; Hongcheng Li; Wei Liu; Thanh Wang; Guibin Jiang
Journal:  Aquat Toxicol       Date:  2009-12-01       Impact factor: 4.964

9.  Antitumor activity of colloidal silver on MCF-7 human breast cancer cells.

Authors:  Moisés A Franco-Molina; Edgar Mendoza-Gamboa; Crystel A Sierra-Rivera; Ricardo A Gómez-Flores; Pablo Zapata-Benavides; Paloma Castillo-Tello; Juan Manuel Alcocer-González; Diana F Miranda-Hernández; Reyes S Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  J Exp Clin Cancer Res       Date:  2010-11-16

10.  Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.

Authors:  Jameel Ahmad Khan; Rachel A Kudgus; Annamaria Szabolcs; Shamit Dutta; Enfeng Wang; Sheng Cao; Geoffry L Curran; Vijay Shah; Steven Curley; Debabrata Mukhopadhyay; J David Robertson; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

View more
  110 in total

1.  Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.

Authors:  Yi-Hsien Cheng; Jim E Riviere; Nancy A Monteiro-Riviere; Zhoumeng Lin
Journal:  Nanotoxicology       Date:  2018-04-14       Impact factor: 5.913

Review 2.  Composites of Polymer Hydrogels and Nanoparticulate Systems for Biomedical and Pharmaceutical Applications.

Authors:  Fuli Zhao; Dan Yao; Ruiwei Guo; Liandong Deng; Anjie Dong; Jianhua Zhang
Journal:  Nanomaterials (Basel)       Date:  2015-12-03       Impact factor: 5.076

3.  Anticancer agents: Unleash the forces within.

Authors:  Weiwei Gao; Liangfang Zhang
Journal:  Nat Chem       Date:  2012-12       Impact factor: 24.427

4.  Metallic Nanoparticles for Cancer Immunotherapy.

Authors:  Emily Reiser Evans; Pallavi Bugga; Vishwaratn Asthana; Rebekah Drezek
Journal:  Mater Today (Kidlington)       Date:  2017-12-14       Impact factor: 31.041

Review 5.  Nanoways to overcome docetaxel resistance in prostate cancer.

Authors:  Aditya Ganju; Murali M Yallapu; Sheema Khan; Stephen W Behrman; Subhash C Chauhan; Meena Jaggi
Journal:  Drug Resist Updat       Date:  2014-04-05       Impact factor: 18.500

6.  Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles.

Authors:  Christian Pfeiffer; Christoph Rehbock; Dominik Hühn; Carolina Carrillo-Carrion; Dorleta Jimenez de Aberasturi; Vivian Merk; Stephan Barcikowski; Wolfgang J Parak
Journal:  J R Soc Interface       Date:  2014-04-23       Impact factor: 4.118

7.  Evaluation of the antioxidant, antibacterial and anticancer (lung cancer cell line A549) activity of Punica granatum mediated silver nanoparticles.

Authors:  Shakeel Ahmed; Gurpreet Kaur; Praveen Sharma; Sandeep Singh; Saiqa Ikram
Journal:  Toxicol Res (Camb)       Date:  2018-05-29       Impact factor: 3.524

8.  Ultrastable silver nanoparticles.

Authors:  Anil Desireddy; Brian E Conn; Jingshu Guo; Bokwon Yoon; Robert N Barnett; Bradley M Monahan; Kristin Kirschbaum; Wendell P Griffith; Robert L Whetten; Uzi Landman; Terry P Bigioni
Journal:  Nature       Date:  2013-09-04       Impact factor: 49.962

9.  Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose.

Authors:  Wen Yang; Hanitrarimalala Veroniaina; Xiaole Qi; Pengyu Chen; Feng Li; Pu Chun Ke
Journal:  Adv Ther (Weinh)       Date:  2019-10-16

10.  Green synthesis of bimetallic Au@Pt nanostructures and their application for proliferation inhibition and apoptosis induction in human cervical cancer cell.

Authors:  Ali A Alshatwi; Jegan Athinarayanan; Vaiyapuri Subbarayan Periasamy
Journal:  J Mater Sci Mater Med       Date:  2015-03-13       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.